The role of vitamin D in innate immunity: Antimicrobial activity, oxidative stress and barrier function

Vitamin D

Volumn , Issue , 2011, Pages 1811-1823

  Liu, Philip T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874000352     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10093-9     Document Type: Chapter

References (153)

1. Kappelman J., Alcicek M.C., Kazanci N., Schultz M., Ozkul M., Sen S. First Homo erectus from Turkey and implications for migrations into temperate Eurasia. Am. J. Phys. Anthropol. 2008, 135:110-116.
2. Raviglione M.C. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb.) 2003, 83:4-14.
3. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 2003, 163:1009-1021.
4. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
5. Gandhi N.R., Moll A., Sturm A.W., Pawinski R., Govender T., Lalloo U., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368:1575-1580.
6. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285:732-736.
7. Krutzik S.R., Tan B., Li H., Ochoa M.T., Liu P.T., Sharfstein S.E., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 2005, 11:653-660.
8. Hertz C.J., Kiertscher S.M., Godowski P.J., Bouis D.A., Norgard M.V., Roth M.D., et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 2001, 166:2444-2450.
9. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291:1544-1547.
10. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
11. Reiling N., Holscher C., Fehrenbach A., Kroger S., Kirschning C.J., Goyert S., et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 2002, 169:3480-3484.
12. Drennan M.B., Nicolle D., Quesniaux V.J., Jacobs M., Allie N., Mpagi J., et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am. J. Pathol. 2004, 164:49-57.
13. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 2005, 202:1715-1724.
14. Ogus A.C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 2004, 23:219-223.
15. Ben-Ali M., Barbouche M.R., Bousnina S., Chabbou A., Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 2004, 11:625-626.
16. Yim J.J., Lee H.W., Lee H.S., Kim Y.W., Han S.K., Shim Y.S., et al. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun. 2006, 7:150-155.
17. Bornman L., Campbell S.J., Fielding K., Bah B., Sillah J., Gustafson P., et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J. Infect. Dis. 2004, 190:1631-1641.
18. Bellamy R., Ruwende C., Corrah T., McAdam K.P., Thursz M., Whittle H.C., et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 1999, 179:721-724.
19. Selvaraj P., Narayanan P.R., Reetha A.M. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients & resistance in female contacts. Indian J. Med. Res. 2000, 111:172-179.
20. Liu W., Cao W.C., Zhang C.Y., Tian L., Wu X.M., Habbema J.D., et al. VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study. Int. J. Tuberc. Lung Dis. 2004, 8:428-434.
21. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000, 355:618-621.
22. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54 Pt. 1:1-13.
23. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
24. Meister M., Lemaitre B., Hoffmann J.A. Antimicrobial peptide defense in Drosophila. Bioessays 1997, 19:1019-1026.
25. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
26. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 2007, 282:36223-36229.
27. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003, 278:8869-8872.
28. Delbridge L.M., O'Riordan M.X. Innate recognition of intracellular bacteria. Curr. Opin. Immunol. 2007, 19:10-16.
29. Zhang D., Zhang G., Hayden M.S., Greenblatt M.B., Bussey C., Flavell R.A., et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004, 303:1522-1526.
30. Dunne A., O'Neill L.A. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett. 2005, 579:3330-3335.
31. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
32. Doyle S.E., O'Connell R.M., Miranda G.A., Vaidya S.A., Chow E.K., Liu P.T., et al. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 2004, 199:81-90.
33. Blander J.M., Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004, 304:1014-1018.
34. Hertz C.J., Wu Q., Porter E.M., Zhang Y.J., Weismuller K.H., Godowski P.J., et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J. Immunol. 2003, 171:6820-6826.
35. Birchler T., Seibl R., Buchner K., Loeliger S., Seger R., Hossle J.P., et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 2001, 31:3131-3137.
36. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17:251-263.
37. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
38. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004, 5:1061-1068.
39. Schmidt H.H., Hofmann H., Schindler U., Shutenko Z.S., Cunningham D.D., Feelisch M. No.NO from NO synthase. Proc. Natl. Acad. Sci. USA 1996, 93:14492-14497.
40. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 2008, 4:e6.
41. Ferwerda G., Girardin S.E., Kullberg B.J., Le B.L., de Jong D.J., Langenberg D.M., et al. NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog. 2005, 1:279-285.
42. Gandotra S., Jang S., Murray P.J., Salgame P., Ehrt S. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 2007, 75:5127-5134.
43. Divangahi M., Mostowy S., Coulombe F., Kozak R., Guillot L., Veyrier F., et al. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 2008, 181:7157-7165.
44. Austin C.M., Ma X., Graviss E.A. Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. J. Infect. Dis. 2008, 197:1713-1716.
45. Stockton J.C., Howson J.M., Awomoyi A.A., McAdam K.P., Blackwell J.M., Newport M.J. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis. FEMS. Immunol. Med. Microbiol. 2004, 41:157-160.
46. Wang T.T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., Tavera-Mendoza L.E., et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 2010, 285:2227-2231.
47. Cantorna M.T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 2006, 92:60-64.
48. Deluca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001, 15:2579-2585.
49. Holick M.F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 2006, 116:2062-2072.
50. Rook G.A., Steele J., Fraher L., Barker S., Karmali R., O'Riordan J., et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986, 57:159-163.
51. Crowle A.J., Ross E.J., May M.H. Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect. Immun. 1987, 55:2945-2950.
52. Sly L.M., Lopez M., Nauseef W.M., Reiner N.E. 1Alpha,25-dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 2001, 276:35482-35493.
53. Anand P.K., Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. FEMS Microbiol. Lett. 2005, 250:137-144.
54. Anand P.K., Kaul D. Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem. Biophys. Res. Commun. 2003, 310:876-877.
55. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173:2909-2912.
56. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
57. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179:2060-2063.
58. Adorini L., Penna G., Giarratana N., Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell Biochem. 2003, 88:227-233.
59. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di L.P., Lang R., et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998, 101:252-262.
60. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 98:6800-6805.
61. Hewison M., Gacad M.A., Lemire J., Adams J.S. Vitamin D as a cytokine and hematopoietic factor. Rev. Endocr. Metab. Disord. 2001, 2:217-227.
62. Lemire J.M. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 1995, 53:599-602.
63. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98:7498-7503.
64. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
65. Hoover D.M., Boulegue C., Yang D., Oppenheim J.J., Tucker K., Lu W., et al. The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J. Biol. Chem. 2002, 277:37647-37654.
66. Niyonsaba F., Ogawa H., Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004, 111:273-281.
67. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
68. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
69. Oppenheim J.J., Biragyn A., Kwak L.W., Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 2003, 62(Suppl. 2):ii17-ii21.
70. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheim J.J., Chertov O., et al. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 2000, 275:32911-32918.
71. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004, 75:39-48.
72. Ahmad I., Perkins W.R., Lupan D.M., Selsted M.E., Janoff A.S. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta 1995, 1237:109-114.
73. Shin S.Y., Kang S.W., Lee D.G., Eom S.H., Song W.K., Kim J.I. CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Biochem. Biophys. Res. Commun. 2000, 275:904-909.
74. Giacometti A., Cirioni O., Barchiesi F., Caselli F., Scalise G. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. J. Antimicrob. Chemother. 1999, 44:403-406.
75. Cirioni O., Giacometti A., Barchiesi F., Scalise G. In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii. J. Antimicrob. Chemother. 1998, 42:445-451.
76. Tamamura H., Murakami T., Horiuchi S., Sugihara K., Otaka A., Takada W., et al. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem. Pharm. Bull (Tokyo) 1995, 43:853-858.
77. Meyer T., Stockfleth E., Christophers E. Immune response profiles in human skin. Br. J. Dermatol. 2007, 157(Suppl. 2):1-7.
78. Sorensen O., Arnljots K., Cowland J.B., Bainton D.F., Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997, 90:2796-2803.
79. Di N.A., Vitiello A., Gallo R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 2003, 170:2274-2278.
80. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000, 96:3086-3093.
81. Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 2007, 178:7190-7198.
82. Rivas-Santiago B., Schwander S.K., Sarabia C., Diamond G., Klein-Patel M.E., Hernandez-Pando R., et al. Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect. Immun. 2005, 73:4505-4511.
83. Sow F.B., Florence W.C., Satoskar A.R., Schlesinger L.S., Zwilling B.S., Lafuse W.P. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J. Leukoc. Biol. 2007, 82:934-945.
84. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 2000, 97:8841-8848.
85. Clark R.A., Leidal K.G., Pearson D.W., Nauseef W.M. NADPH oxidase of human neutrophils. Subcellular localization and characterization of an arachidonate-activatable superoxide-generating system. J. Biol. Chem. 1987, 262:4065-4074.
86. Borregaard N., Heiple J.M., Simons E.R., Clark R.A. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J. Cell Biol. 1983, 97:52-61.
87. Fang F.C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2004, 2:820-832.
88. Tosi M.F. Innate immune responses to infection. J. Allergy Clin. Immunol. 2005, 116:241-249.
89. Cadwallader K.A., Condliffe A.M., McGregor A., Walker T.R., White J.F., Stephens L.R., et al. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. J. Immunol. 2002, 169:3336-3344.
90. Levy R., Malech H.L. Effect of 1,25-dihydroxyvitamin D3, lipopolysaccharide, or lipoteichoic acid on the expression of NADPH oxidase components in cultured human monocytes. J. Immunol. 1991, 147:3066-3071.
91. Cassatella M.A., Bazzoni F., Flynn R.M., Dusi S., Trinchieri G., Rossi F. Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J. Biol. Chem. 1990, 265:20241-20246.
92. Li H., Poulos T.L. Structure-function studies on nitric oxide synthases. J. Inorg. Biochem. 2005, 99:293-305.
93. Bogdan C., Rollinghoff M., Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 2000, 173:17-26.
94. Hurshman A.R., Krebs C., Edmondson D.E., Huynh B.H., Marletta M.A. Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen. Biochemistry 1999, 38:15689-15696.
95. Schapiro J.M., Libby S.J., Fang F.C. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc. Natl. Acad. Sci. USA 2003, 100:8496-8501.
96. Pacelli R., Wink D.A., Cook J.A., Krishna M.C., DeGraff W., Friedman N., et al. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 1995, 182:1469-1479.
97. Stevanin T.M., Ioannidis N., Mills C.E., Kim S.O., Hughes M.N., Poole R.K. Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide. J. Biol. Chem. 2000, 275:35868-35875.
98. Lepoivre M., Fieschi F., Coves J., Thelander L., Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 1991, 179:442-448.
99. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991, 254:1001-1003.
100. Burney S., Caulfield J.L., Niles J.C., Wishnok J.S., Tannenbaum S.R. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 1999, 424:37-49.
101. Spek E.J., Wright T.L., Stitt M.S., Taghizadeh N.R., Tannenbaum S.R., Marinus M.G., et al. Recombinational repair is critical for survival of Escherichia coli exposed to nitric oxide. J. Bacteriol. 2001, 183:131-138.
102. Evans T.J., Buttery L.D., Carpenter A., Springall D.R., Polak J.M., Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA 1996, 93:9553-9558.
103. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
104. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994, 263:1612-1615.
105. Taylor B.S., Geller D.A. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 2000, 13:413-424.
106. Watkins S.C., Macaulay W., Turner D., Kang R., Rubash H.E., Evans C.H. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am. J. Pathol. 1997, 150:1199-1206.
107. Chen F., Kuhn D.C., Gaydos L.J., Demers L.M. Induction of nitric oxide and nitric oxide synthase mRNA by silica and lipopolysaccharide in PMA-primed THP-1 cells. APMIS 1996, 104:176-182.
108. Jagannath C., Actor J.K., Hunter R.L. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 1998, 2:174-186.
109. Baek S.H., Kwon T.K., Lim J.H., Lee Y.J., Chang H.W., Lee S.J., et al. Secretory phospholipase A2-potentiated inducible nitric oxide synthase expression by macrophages requires NF-kappa B activation. J. Immunol. 2000, 164:6359-6365.
110. Weinberg J.B., Misukonis M.A., Shami P.J., Mason S.N., Sauls D.L., Dittman W.A., et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995, 86:1184-1195.
111. Adams J.S., Ren S.Y., Arbelle J.E., Shany S., Gacad M.A. Coordinate regulation of nitric oxide and 1,25-dihydroxyvitamin D production in the avian myelomonocytic cell line HD-11. Endocrinology 1995, 136:2262-2269.
112. Adams J.S., Ren S.Y. Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide. Endocrinology 1996, 137:4514-4517.
113. Chang J.M., Kuo M.C., Kuo H.T., Hwang S.J., Tsai J.C., Chen H.C., et al. 1-Alpha,25-dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J. Lab. Clin. Med. 2004, 143:14-22.
114. Garcion E., Sindji L., Montero-Menei C., Andre C., Brachet P., Darcy F. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia 1998, 22:282-294.
115. Nelson C.D., Reinhardt T.A., Thacker T.C., Beitz D.C., Lippolis J.D. Modulation of the bovine innate immune response by production of 1alpha,25-dihydroxyvitamin D(3) in bovine monocytes. J. Dairy Sci. 2010, 93:1041-1049.
116. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
117. Alonso S., Pethe K., Russell D.G., Purdy G.E. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. USA. 2007, 104:6031-6036.
118. Yuk J.M., Shin D.M., Lee H.M., Yang C.S., Jin H.S., Kim K.K., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
119. Xu Y., Jagannath C., Liu X.D., Sharafkhaneh A., Kolodziejska K.E., Eissa N.T. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007, 27:135-144.
120. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., Deretic V. Toll-like receptors control autophagy. EMBO J. 2008, 27:1110-1121.
121. Hewison M., Zehnder D., Chakraverty R., Adams J.S. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol. Cell Endocrinol. 2004, 215:31-38.
122. Hertz C.J., Wu Q., Porter E.M., Zhang Y.J., Weismuller K.H., Godowski P.J., et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J. Immunol. 2003, 171:6820-6826.
123. Ritter M., Mennerich D., Weith A., Seither P. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I: C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. (Lond.) 2005, 2(16):16.
124. Sha Q., Truong-Tran A.Q., Plitt J.R., Beck L.A., Schleimer R.P. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 2004, 31:358-364.
125. Hansdottir S., Monick M.M., Hinde S.L., Lovan N., Look D.C., Hunninghake G.W. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J. Immunol. 2008, 181:7090-7099.
126. Ravikumar M., Dheenadhayalan V., Rajaram K., Lakshmi S.S., Kumaran P.P., Paramasivan C.N., et al. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tuber. Lung Dis. 1999, 79:309-317.
127. Mehra N.K., Rajalingam R., Mitra D.K., Taneja V., Giphart M.J. Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians. Int. J. Lepr. Other Mycobact. Dis. 1995, 63:241-248.
128. Amirzargar A.A., Yalda A., Hajabolbaghi M., Khosravi F., Jabbari H., Rezaei N., et al. The association of HLA-DRB, DQA1, DQB1 alleles and haplotype frequency in Iranian patients with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2004, 8:1017-1021.
129. Liu J., Fujiwara T.M., Buu N.T., Sanchez F.O., Cellier M., Paradis A.J., et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am. J. Hum. Genet. 1995, 56:845-853.
130. Jouanguy E., Lamhamedi-Cherradi S., Lammas D., Dorman S.E., Fondaneche M.C., Dupuis S., et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 1999, 21:370-378.
131. Pan H., Yan B.S., Rojas M., Shebzukhov Y.V., Zhou H., Kobzik L., et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005, 434:767-772.
132. Fitness J., Floyd S., Warndorff D.K., Sichali L., Mwaungulu L., Crampin A.C., et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am. J. Trop. Med. Hyg. 2004, 71:330-340.
133. Grange J.M., Davies P.D., Brown R.C., Woodhead J.S., Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985, 66:187-191.
134. Delgado J.C., Baena A., Thim S., Goldfeld A.E. Ethnic-specific genetic associations with pulmonary tuberculosis. J. Infect. Dis. 2002, 186:1463-1468.
135. Uitterlinden A.G., Fang Y., Van Meurs J.B., Pols H.A., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338:143-156.
136. Hewison M., Freeman L., Hughes S.V., Evans K.N., Bland R., Eliopoulos A.G., et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003, 170:5382-5390.
137. Hewison M., Burke F., Evans K.N., Lammas D.A., Sansom D.M., Liu P., et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 2007, 103:316-321.
138. Yang S., Smith C., Prahl J.M., Luo X., Deluca H.F. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch. Biochem. Biophys. 1993, 303:98-106.
139. Lathers D.M., Clark J.I., Achille N.J., Young M.R. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3. Cancer Immunol. Immunother. 2004, 53:422-430.
140. Krutzik S.R., Hewison M., Liu P.T., Robles J.A., Stenger S., Adams J.S., et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 2008, 181:7115-7120.
141. Liu P.T., Schenk M., Walker V.P., Dempsey P.W., Kanchanapoomi M., Wheelwright M., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009, 4:e5810.
142. Wilkinson R.J., Patel P., Llewelyn M., Hirsch C.S., Pasvol G., Snounou G., et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. 1999, 189:1863-1874.
143. Fremond C.M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 2007, 179:1178-1189.
144. Barnes P.F., Modlin R.L., Bikle D.D., Adams J.S. Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. J. Clin. Invest. 1989, 83:1527-1532.
145. Hagenau T., Vest R., Gissel T.N., Poulsen C.S., Erlandsen M., Mosekilde L., et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos. Int. 2009, 20:133-140.
146. Adams J.S., Ren S., Liu P.T., Chun R.F., Lagishetty V., Gombart A.F., et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 2009, 182:4289-4295.
147. Martineau A.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Kampmann B., Hall B.M., et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 2007, 176:208-213.
148. Shin D.M., Yuk J.M., Lee H.M., Lee S.H., Son J.W., Harding C.V., et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signaling. Cell Microbiol. 2010, 12(11):1648-1665.
149. Dowling G.B., Thomas E.W. Treatment of lupus vulgaris with calciferol. Lancet 1946, 919-923.
150. Morcos M.M., Gabr A.A., Samuel S., Kamel M., el Baz M., el Beshry M., et al. Vitamin D administration to tuberculous children and its value. Boll. Chim. Farm. 1998, 137:157-164.
151. Nursyam E.W., Amin Z., Rumende C.M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta. Med. Indones. 2006, 38:3-5.
152. Zahrt T.C., Deretic V. Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc. Natl. Acad. Sci. USA 2001, 98:12706-12711.
153. Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol. 2007, 103:793-798.